Point-of-Care (POC) Infectious Disease Diagnostics Market Point-of-Care (POC) Infectious Disease Diagnostics | Page 2

REPORT DESCRIPTION
Point-of-care infectious disease diagnostics market has grown manifold over the last 20
years, driving major profits across value chains. The industry witnessed slow growth during
2005–2010 before taking a major leap with adoption of mobile technology. Point-of-care
testing or bed-side testing refers to tests that are performed near the site of patient care.
These tests can potentially improve detection and management of infectious diseases by
reducing time between tests and results. These testing aids in reduction of operating times,
postoperative care time, and high-dependency, thereby ensuring optimal use of professional
time. Urine test strips and imaging tests such as portable ultrasound and ECG tests are some
examples of point-of-care testing. Point-of-care testing for infectious diseases includes rapid,
reliable, and affordable tests for HIV infection, malaria, dengue fever, hepatitis, influenza,
and pneumonia. Point-of-testing for infectious diseases exhibit a major opportunity for
pharmacy services for expansion. Improvement in disease outcomes, simple and accurate
tests, and rapid disease outcome and results are few of the advantages of point-of-care
testing.
The billion dollar point-of-care infectious disease diagnostic market is expected to grow at a
substantial rate over the forecast period (2016–2024).
© Coherent market Insights. All Rights Reserved